Concepedia

507O EXCLAIM-2: Phase III trial of first-line (1L) mobocertinib versus platinum-based chemotherapy in patients (pts) with epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)+ locally advanced/metastatic NSCLC

Pasi A. Jänne, BC Wang, Byoung Chul Cho, Jun Zhao, Jiaqi Li, Maximilian J. Hochmair, Solange Peters, Benjamin Besse, Terufumi Kato, Yi‐Long Wu,

Annals of Oncology · 2023 · 36 citations · 0 references

Open access

Concepts

MedicineOncologyPharmacologyChemotherapyMetastasisMolecular OncologyCytotoxic ChemotherapyMetastatic Disease TreatmentTargeted Cancer TherapyTargeted TherapyEgfr InhibitionEgfr Mutation TestingEpidermal Growth Factor Receptor InhibitionEpidermal Growth Factor Receptor SignalingErlotinib TherapyPlatinum-based AgentsPlatinum-based Regimens